PKMYT1 inhibits lung adenocarcinoma progression by abrogating AKT1 activity.
Wang S, Liu X, Zhou T, Li J, Lin Y, Zhou A, Huang J, Zhao J, Cai J, Cai X, Huang Y, Li X.
Wang S, et al. Among authors: li j, li x.
Cell Oncol (Dordr). 2023 Feb;46(1):195-209. doi: 10.1007/s13402-022-00744-y. Epub 2022 Nov 9.
Cell Oncol (Dordr). 2023.
PMID: 36350496